XML 102 R2.htm IDEA: XBRL DOCUMENT v3.25.1
Pay vs Performance Disclosure - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Pay vs Performance Disclosure          
Pay vs Performance Disclosure, Table
Year(1)
Summary Compensation Table Total for CEO/PEO ($)
Compensation Actually Paid to CEO/PEO ($)(2)
Average Summary Compensation Table for Non-PEO Named Executive Officers ($)
Average Compensation Actually Paid to Non-PEO Named Executive Officers ($)(3)
Value of Initial Fixed $100
Investment Based On:		Net Income
($ millions)
Adjusted
Net Sales
($ millions)(5)
Total Shareholder Return ($)
Peer Group Total Shareholder Return ($)(4)
202421,420,801 65,818,468 5,515,833 15,177,435 197.52 148.31 1,84616,741 
202318,723,735 38,596,387 4,865,206 9,121,400 127.84 143.18 1,592 14,257 
202216,941,961 21,632,710 4,884,001 5,984,751 102.32 140.29 698 13,206 
202116,064,039 20,440,299 3,905,481 4,972,710 93.94 143.09 1,041 11,646 
202013,773,795 (5,088,265)3,705,762 (443,641)79.50 113.45 (82)9,955 
        
Company Selected Measure Name Adjusted Net Sales        
Named Executive Officers, Footnote The CEO/PEO and NEO/Non-PEO Named Executive Officers included in the above compensation columns reflect the following:
YearCEO/PEONon-PEO NEOs
2024
Michael F. MahoneyDaniel J. Brennan, Joseph M. Fitzgerald, Jeffrey B. Mirviss and Arthur C. Butcher
2023Michael F. MahoneyDaniel J. Brennan, Joseph M. Fitzgerald, Jeffrey B. Mirviss and Arthur C. Butcher
2022Michael F. Mahoney
Daniel J. Brennan, Joseph M. Fitzgerald, Jeffrey B. Mirviss and Arthur C. Butcher
2021Michael F. Mahoney
Daniel J. Brennan, Joseph M. Fitzgerald, Jeffrey B. Mirviss and David A. Pierce
2020Michael F. Mahoney
Daniel J. Brennan, Joseph M. Fitzgerald, Jeffrey B. Mirviss and Edward F. Mackey
        
Peer Group Issuers, Footnote We selected the Standard & Poor (S&P) 500 Health Care Index (referred to herein as the “Health Care Index”) as our peer group for purposes of this disclosure, which was comprised of 61-64 companies for the years 2020 through 2024 included in the S&P 500 that are classified as members of the GICS® Health Care sector primarily engaged in Health Care Equipment and Services, Pharmaceuticals, Biotechnology and Life Sciences, including the Company and other mid-cap and large-cap healthcare companies. The Health Care Index is the same performance peer group selected by the Compensation Committee for determining the achievement of targets of TSR performance-based RSUs granted to our NEOs, including our CEO, between 2020 and 2024. See Long Term Incentives on page 62 for additional information.        
PEO Total Compensation Amount $ 21,420,801 $ 18,723,735 $ 16,941,961 $ 16,064,039 $ 13,773,795
PEO Actually Paid Compensation Amount $ 65,818,468 38,596,387 21,632,710 20,440,299 (5,088,265)
Adjustment To PEO Compensation, Footnote "Compensation Actually Paid" to the CEO/PEO reflect the following adjustments from the amount reported in the “Total” compensation column of the Summary Compensation Table on page 72 of this Proxy Statement.
Adjustments to Determine Compensation “Actually Paid” for CEO/PEO
2024
($)
2023
($)
2022
($)
2021
($)
2020
($)
Total Reported in Summary Compensation Table21,420,801 18,723,735 16,941,961 16,064,039 13,773,795 
Less Change in Actuarial Present Value reported under the “Change in Pension Value and Non-qualified Deferred Compensation Earnings” Column of the SCT
291,666 291,667 376,667 360,000 399,686 
Plus “Service Cost” for Pension Plans
— — — — 375,972 
Less Amounts Reported under the “Stock Awards” Column of the SCT
12,229,998 10,472,753 9,924,100 9,126,292 8,395,367 
Less Amounts Reported under the “Option Awards” Column of the SCT
3,562,493 3,124,984 2,874,985 2,749,999 2,749,991 
Plus the Fair Value of Awards Granted during covered year that Remain Unvested as of Year-end
30,707,960 22,483,365 13,748,034 14,273,008 7,458,564 
Plus the Change in Fair Value from prior Year-end to current Year-end of Awards Granted prior to covered year that were Outstanding and Unvested as of Year-end
26,602,863 11,223,191 4,283,677 2,596,137 (13,208,804)
Plus the Change in Fair Value from prior Year-end to Vesting Date of Awards Granted prior to covered year that Vested during covered year
3,171,001 55,500 315,254 903,733 (1,942,748)
Less the Fair Value as of prior Year-End of Awards Granted prior to covered year that were Forfeited during covered year
— — 480,464 1,160,327 — 
Total Adjustments
44,397,667 19,872,652 4,690,749 4,376,260 (18,862,060)
Compensation Actually Paid65,818,468 38,596,387 21,632,710 20,440,299 (5,088,265)

*Compensation Actually Paid” does not correlate to the total amount of cash or equity compensation realized during each fiscal year and is different from “realizable” or “realized” compensation as reported in the Compensation Discussion & Analysis section of this Proxy Statement. Instead, it is a nuanced calculation that includes the increase or decrease in value of certain elements of compensation over each fiscal year, including compensation granted in a prior year, in accordance with Item 402(v) of Regulation S-K. The amount of compensation ultimately received may, in fact, be different from the amounts disclosed in these columns of the Pay Versus Performance Table.
        
Non-PEO NEO Average Total Compensation Amount $ 5,515,833 4,865,206 4,884,001 3,905,481 3,705,762
Non-PEO NEO Average Compensation Actually Paid Amount $ 15,177,435 9,121,400 5,984,751 4,972,710 (443,641)
Adjustment to Non-PEO NEO Compensation Footnote The average "Compensation Actually Paid" to the Non-PEO NEOs reflect the following adjustments from the amount reported in the “Total” compensation column of the Summary Compensation Table on page 72.
Adjustments to Determine Average Compensation “Actually Paid” for Non-PEO NEOs
2024 Average
($)
2023 Average
($)
2022 Average
($)
2021 Average
($)
2020 Average
($)
Total Reported in Summary Compensation Table5,515,833 4,865,206 4,884,001 3,905,481 3,705,762 
Less Change in Actuarial Present Value reported under the “Change in Pension Value and Non-qualified Deferred Compensation Earnings” Column of the SCT
145,042 121,759 122,326 59,942 121,136 
Plus “Service Cost” for Pension Plans
16,633 15,308 16,435 — 67,192 
Less Amounts Reported under the “Stock Awards” Column of the SCT
2,660,420 2,324,937 2,180,154 1,918,553 1,852,695 
Less Amounts Reported under the “Option Awards” Column of the SCT
774,991 693,748 693,740 578,120 774,993 
Plus the Fair Value of Awards Granted during covered year that Remain Unvested as of Year-end
6,680,034 4,991,284 3,103,987 3,000,519 1,937,832 
Plus the Change in Fair Value from prior Year-end to current Year-end of Awards Granted prior to covered year that were Outstanding and Unvested as of Year-end
5,867,592 2,367,857 1,004,348 636,900 (2,652,595)
Plus the Change in Fair Value from prior Year-end to Vesting Date of Awards Granted prior to covered year that Vested during covered year
677,794 22,189 65,014 208,010 (753,008)
Less the Fair Value as of prior Year-End of Awards Granted prior to covered year that were Forfeited during covered year
— — 92,814 221,585 — 
Total Adjustments
9,661,602 4,256,194 1,100,750 1,067,229 (4,149,403)
Compensation Actually Paid15,177,435 9,121,400 5,984,751 4,972,710 (443,641)
“Compensation Actually Paid” does not correlate to the total amount of cash or equity compensation realized during each fiscal year and is different from “realizable” or “realized” compensation as reported in the Compensation Discussion & Analysis section of this Proxy Statement. Instead, it is a nuanced calculation that includes the increase or decrease in value of certain elements of compensation over each fiscal year, including compensation granted in a prior year, in accordance with Item 402(v) of Regulation S-K. The amount of compensation ultimately received may, in fact, be different from the amounts disclosed in these columns of the Pay Versus Performance Table.
        
Compensation Actually Paid vs. Total Shareholder Return
The graph below shows the relationship between (i) the four-year total return to stockholders on our common stock and the return on the Health Care Index, in each case assuming $100 was invested in our common stock and in the Health Care Index on December 31, 2020 and that any dividends were reinvested, and (ii) the CAP for our CEO/PEO and the average CAP for our non-PEO NEOs for each of 2020 through 2024.
Relationship Between Compensation Actually Paid and Company/Peer Group Total Shareholder Return
4398046526723
        
Compensation Actually Paid vs. Net Income
The graph below shows the relationship between our net income and the CAP for our CEO/PEO and the average CAP for our non-PEO NEOs for each of 2020 through 2024.
Relationship Between Compensation Actually Paid and Net Income
4398046526753
        
Compensation Actually Paid vs. Company Selected Measure
The graph below shows the relationship between our Adjusted Net Sales and the CAP for our CEO/PEO and the average CAP for our non-PEO NEOs for each of 2020 through 2024.
Relationship Between Compensation Actually Paid and Adjusted Net Sales
4398046526765
        
Tabular List, Table
Adjusted Net Sales*
Adjusted EPS*
Adjusted Operating Income Margin*
Organic Net Sales Growth*
Relative Total Shareholder Return
        
Total Shareholder Return Amount $ 197.52 127.84 102.32 93.94 79.50
Peer Group Total Shareholder Return Amount 148.31 143.18 140.29 143.09 113.45
Net Income (Loss) $ 1,846 $ 1,592 $ 698 $ 1,041 $ (82)
Company Selected Measure Amount 16,741 14,257 13,206 11,646 9,955
PEO Name Michael F. Mahoney Michael F. Mahoney Michael F. Mahoney Michael F. Mahoney Michael F. Mahoney
Additional 402(v) Disclosure *    Adjusted Net Sales, Adjusted EPS, Adjusted Operating Income Margin and Organic Net Sales Growth are not prepared in accordance with GAAP. For a reconciliation of these non-GAAP financial measures to the most directly comparable GAAP financial measures and insight into how these non-GAAP financial measures are considered by management, please see Annex A to this Proxy Statement.        
Measure:: 1          
Pay vs Performance Disclosure          
Name Adjusted Net Sales*        
Non-GAAP Measure Description Adjusted Net Sales represents the most important financial performance measure (that is not otherwise required to be disclosed in the table) used by the Company to link CAP to our NEOs, including our CEO, for the most recently completed fiscal year to the Company’s performance. Adjusted Net Sales is a non-GAAP financial measure. For a reconciliation of Adjusted Net Sales to the most directly comparable GAAP financial measure and insight into how Adjusted Net Sales is considered by management, please see Annex A to this Proxy Statement.        
Measure:: 2          
Pay vs Performance Disclosure          
Name Adjusted EPS*        
Measure:: 3          
Pay vs Performance Disclosure          
Name Adjusted Operating Income Margin*        
Measure:: 6          
Pay vs Performance Disclosure          
Name Organic Net Sales Growth*        
Measure:: 7          
Pay vs Performance Disclosure          
Name Relative Total Shareholder Return        
PEO          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount $ 44,397,667 $ 19,872,652 $ 4,690,749 $ 4,376,260 $ (18,862,060)
PEO | Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (291,666) (291,667) (376,667) (360,000) (399,686)
PEO | Pension Adjustments Service Cost          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 0 0 0 0 375,972
PEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (12,229,998) (10,472,753) (9,924,100) (9,126,292) (8,395,367)
PEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 30,707,960 22,483,365 13,748,034 14,273,008 7,458,564
PEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 26,602,863 11,223,191 4,283,677 2,596,137 (13,208,804)
PEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 3,171,001 55,500 315,254 903,733 (1,942,748)
PEO | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 0 0 (480,464) (1,160,327) 0
PEO | Adjustment, Option Awards [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (3,562,493) (3,124,984) (2,874,985) (2,749,999) (2,749,991)
Non-PEO NEO          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 9,661,602 4,256,194 1,100,750 1,067,229 (4,149,403)
Non-PEO NEO | Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (145,042) (121,759) (122,326) (59,942) (121,136)
Non-PEO NEO | Pension Adjustments Service Cost          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 16,633 15,308 16,435 0 67,192
Non-PEO NEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (2,660,420) (2,324,937) (2,180,154) (1,918,553) (1,852,695)
Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 6,680,034 4,991,284 3,103,987 3,000,519 1,937,832
Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 5,867,592 2,367,857 1,004,348 636,900 (2,652,595)
Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 677,794 22,189 65,014 208,010 (753,008)
Non-PEO NEO | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 0 0 (92,814) (221,585) 0
Non-PEO NEO | Adjustment, Option Awards [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount $ (774,991) $ (693,748) $ (693,740) $ (578,120) $ (774,993)